Igor Snapkov
Igor Snapkov
Postdoctoral researcher, Computational and Systems Immunology research group, University of Oslo
Verified email at medisin.uio.no - Homepage
Title
Cited by
Cited by
Year
Augmenting adaptive immunity: progress and challenges in the quantitative engineering and analysis of adaptive immune receptor repertoires
AJ Brown, I Snapkov, R Akbar, M Pavlović, E Miho, GK Sandve, V Greiff
Molecular Systems Design & Engineering 4 (4), 701-736, 2019
372019
The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis
I Snapkov, CO Öqvist, Y Figenschau, P Kogner, JI Johnsen, ...
BMC cancer 16 (1), 1-12, 2016
342016
A compact vocabulary of paratope-epitope interactions enables predictability of antibody-antigen binding
R Akbar, PA Robert, M Pavlović, JR Jeliazkov, I Snapkov, A Slabodkin, ...
Cell Reports 34 (11), 108856, 2021
262021
Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability in vitro and impairs tumor growth in vivo
C Tümmler, I Snapkov, M Wickström, U Moens, L Ljungblad, LHM Elfman, ...
Oncotarget 8 (56), 95135, 2017
252017
Agnoprotein of polyomavirus BK interacts with proliferating cell nuclear antigen and inhibits DNA replication
N Gerits, M Johannessen, C Tümmler, M Walquist, S Kostenko, I Snapkov, ...
Virology journal 12 (1), 1-14, 2015
252015
immuneSIM: tunable multi-feature simulation of B-and T-cell receptor repertoires for immunoinformatics benchmarking
CR Weber, R Akbar, A Yermanos, M Pavlović, I Snapkov, GK Sandve, ...
Bioinformatics 36 (11), 3594-3596, 2020
192020
Each pregnancy linearly changes immune gene expression in the blood of healthy women compared with breast cancer patients
E Lund, A Nakamura, I Snapkov, JC Thalabard, KS Olsen, L Holden, ...
Clinical epidemiology 10, 931, 2018
102018
FITC conjugation markedly enhances hepatic clearance of N-formyl peptides
CI Øie, I Snapkov, K Elvevold, B Sveinbjørnsson, B Smedsrød
Plos one 11 (8), e0160602, 2016
52016
The future of blood testing is the immunome
RA Arnaout, ETL Prak, N Schwab, F Rubelt
Frontiers in immunology 12, 2021
42021
immuneML: an ecosystem for machine learning analysis of adaptive immune receptor repertoires
M Pavlovic, L Scheffer, K Motwani, C Kanduri, R Kompova, N Vazov, ...
bioRxiv, 2021
32021
In silico proof of principle of machine learning-based antibody design at unconstrained scale
R Akbar, PA Robert, CR Weber, M Widrich, R Frank, M Pavlović, ...
BioRXiV, 2021
22021
A finite vocabulary of antibody-antigen interaction enables predictability of paratope-epitope binding
R Akbar, JR Jeliazkov, PA Robert, I Snapkov, M Pavlović, A Slabodkin, ...
bioRxiv, 759498, 2019
22019
One billion synthetic 3D-antibody-antigen complexes enable unconstrained machine-learning formalized investigation of antibody specificity prediction
PA Robert, R Akbar, R Frank, M Pavlović, M Widrich, I Snapkov, ...
BioRXiV, 2021
12021
Individualized VDJ recombination predisposes the available Ig sequence space
A Slabodkin, M Chernigovskaya, I Mikocziova, R Akbar, L Scheffer, ...
bioRxiv, 2021
12021
Breast cancer women lack normal immune response after full-term pregnancies.
E Lund, A Nakamura, I Snapkov, JC Thalabard, KS Olsen, L Holden, ...
Norsk Epidemiologi 28, 2018
12018
The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis
I Snapkov, CO Öqvist, YA Figenschau, P Kogner, JI Johnsen, ...
Cancer Research 75 (15 Supplement), 3283-3283, 2015
12015
Expression of chemerin and chemerin receptors in neuroblastoma: implications in tumorigenesis
C Tuemmler, I Snapkov, UL Moens, P Kogner, JI Johnsen, ...
Cancer Research 75 (15 Supplement), 3279-3279, 2015
12015
Progress and challenges in mass spectrometry-based analysis of antibody repertoires
I Snapkov, M Chernigovskaya, P Sinitcyn, K Lê Quý, TA Nyman, V Greiff
Trends in Biotechnology, 2021
2021
The blood transcriptome prior to ovarian cancer diagnosis: A case-control study in the NOWAC postgenome cohort
M Jareid, I Snapkov, M Holden, LTR Busund, E Lund, TH Nøst
Plos one 16 (8), e0256442, 2021
2021
Dynamic changes in the T cell receptor repertoire during treatment with radiotherapy combined with an immune checkpoint inhibitor
ÅK Öjlert, D Nebdal, I Snapkov, V Olsen, J Kidman, V Greiff, J Chee, ...
Molecular Oncology, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20